Theravance Biopharma
TBPH
#6135
Rank
$0.43 B
Marketcap
Cayman Islands
Country
$8.99
Share price
-1.43%
Change (1 day)
-18.35%
Change (1 year)
Categories
Operating Margin for Theravance Biopharma (TBPH)
Operating Margin as of April 2024 (TTM): -125.52%
According to Theravance Biopharma 's latest financial reports and stock price the company's current Operating Margin is -125.52%. At the end of 2021 the company had an Operating Margin of -276.05%.
Operating Margin history for Theravance Biopharma from 2013 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -276.05% | -18.02% |
| 2020 | -336.71% | 17.82% |
| 2019 | -285.80% | -19.98% |
| 2018 | -357.14% | -79.12% |
| 2017 | -1,710.41% | 364.45% |
| 2016 | -368.27% | -14.71% |
| 2015 | -431.80% | -78.3% |
| 2014 | -1,989.55% | -97.12% |
| 2013 | -69,152.21% | 939828.43% |
| 2012 | -7.36% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | 28.91% | -123.03% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | 9.19% | -107.32% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | 48.88% | -138.94% | 🇺🇸 USA |
 Catalent CTLT | 4.60% | -103.66% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.